查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1944417

全球荐椎神经刺激疗法市场：产业分析、市场规模、份额及2025-2032年预测（依产品类型、应用、最终用户、患者年龄层、技术、国家及地区划分）

Sacral Neuromodulation Market, By Product Type, By Application, By End User, By Patient Age Group, By Technology, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 374 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024年荐椎神经刺激市场规模价值19.8787亿美元，从2025年到2032年以11.51%的复合年增长率成长。

荐椎神经刺激（SNM）是一种利用电脉衝刺激荐骨神经的医疗治疗方法。该治疗方法透过纠正骨盆器官与大脑之间异常的神经讯号来恢復正常的神经功能。医生通常对膀胱过动症过动症、急性尿失禁和粪便失禁等症状，以及对行为疗法和药物治疗等标准疗法无效的患者采用荐椎神经刺激刺激术。治疗首先进行试验阶段，在此期间，医生会监测患者对测试性刺激的反应。症状显着缓解的患者随后会被植入永久性神经刺激设备。

荐椎神经刺激市场动态

提高公众意识和改善报销途径

荐椎神经刺激市场成长主要归功于两大因素：一是医患教育水平的提高，使得膀胱和肠道疾病的诊断和神经调控疗法得以更早地被接受；二是临床培训项目的拓展、临床证据的强化以及荐椎神经刺激疗法被纳入泌尿系统和胃肠病学治疗指南，这些因素共同提升了医生的信心和转诊率三三是北美认知度的提高和报销体系的完善，改善了患者获得治疗的机会，加速了荐椎神经刺激疗法作为难治性疾病标准疗法的普及，并推动了市场的持续成长。

荐椎神经刺激刺激市场：細項分析

依产品类型

预计在预测期内，植入式脉衝产生器 (IPG) 细分市场将主导市场。荐椎神经刺激刺激系统依赖 IPG 直接连接荐骨神经，输送可控电脉衝，从而治疗骨盆底功能障碍。 IPG 设备是治疗操作的关键组成部分，直接推动了市场需求与荐椎神经刺激疗法的普及应用，并为整个行业带来了可观的收入。小型化设计、长电池寿命、MRI 相容性和可编程性等技术进步，使 IPG 对患者和医生都更加有益。这些改进转化为更高的患者舒适度和更佳的临床疗效，从而提高了产品的使用率和重购率。

荐椎神经刺激刺激市场—区域分析

预计北美将在预测期内引领荐椎神经刺激市场。成长的主要驱动力是骨盆底功能障碍（包括尿失禁和粪便失禁）的高发生率，这导致对有效神经调控治疗的持续需求。该地区拥有完善的医疗保健网络，多家医疗机构提供基于成熟临床实践的先进治疗方案，例如荐椎神经刺激疗法。美国和加拿大目前正在推行更完善的报销政策和更广的保险覆盖范围，降低了患者和医疗机构面临的经济负担，从而提高了荐椎神经刺激疗法的可及性和经济可行性。主要医疗设备製造商的存在以及神经调控系统技术的不断进步，促成了具有更长电池寿命和更高级可编程性的优质植入式设备的开发。这提高了医生和患者的接受度，从而推动了北美市场的收入成长。

目录

第一章 荐荐椎神经刺激市场概览

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章 荐荐椎神经刺激疗法的主要市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

第四章荐椎神经刺激市场：产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望：概览
  • 管理体制分析

第五章荐椎神经刺激市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章 荐荐椎神经刺激市场现状

  • 荐椎神经刺激市场份额分析（2024 年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

第七章 荐荐椎神经刺激刺激市场（依产品类型划分）

  • 概述
    • 细分市场占有率分析：依产品类型
    • 体外/非植入式脉衝产生器（EPG）
    • 铅电极
    • 植入式脉衝产生器（IPG）
    • 附件和系统元件

第八章荐椎神经刺激市场依应用领域划分

  • 概述
    • 细分市场占有率分析：按应用
    • 尿失禁
    • 闭尿症
    • 大便失禁
    • 膀胱过动症
    • 慢性及相关骨盆腔疼痛
    • 其他的

第九章荐椎神经刺激疗法市场（按最终用户划分）

  • 概述
    • 细分市场占有率分析：依最终用户划分
    • 医院及大型医疗中心
    • 门诊手术中心
    • 专科诊所
    • 研究和学术机构

第十章 依患者年龄层分類的荐椎神经刺激疗法市场

  • 概述
    • 细分市场占有率分析：依患者年龄组别划分
    • 成人
    • 儿童
    • 老年人

第十一章荐椎神经刺激市场（依技术划分）

  • 概述
    • 细分市场占有率分析：依技术划分
    • 可充电系统
    • 不可充电系统
    • 有线/引线系统与无线/无引线系统
    • 试验系统与永久系统的比较

第十二章荐椎神经刺激市场（按地区划分）

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十三章 主要供应商分析－荐椎神经刺激产业

  • 竞争对手仪錶板
    • 竞争基准
    • 竞争定位
  • 公司简介
    • BioControl Medical
    • Uroplasty Inc.
    • Cogentix Medical Inc.
    • Cyberonics Inc.
    • Nuvectra Corporation
    • Nevro Corp.
    • Synapse Biomedical Inc.
    • ImThera Medical Inc.
    • Abbott Laboratories
    • Advanced Bionics AG
    • Stryker Corporation
    • Inspire Medical Systems Inc.
    • Laborie Medical Technologies
    • MicroTransponder Inc.
    • Brainsway Ltd.
    • EndoStim Inc.
    • Stimwave LLC

第十四章：分析师视角360度分析

简介目录
Product Code: ANV5985

Sacral Neuromodulation market size was valued at US$ 1,987.87 Million in 2024, expanding at a CAGR of 11.51% from 2025 to 2032.

Sacral neuromodulation (SNM) works as a medical treatment that uses electrical pulses to stimulate sacral nerves. The treatment restores normal nerve function by treating abnormal nerve signals that exist between the pelvic organs and the brain. Doctors use sacral neuromodulation to treat patients who suffer from overactive bladder and urinary urge incontinence, non-obstructive urinary retention, and fecal incontinence when patients do not respond to standard treatments, which include behavioral therapy and medications. The procedure starts with a testing phase, which monitors patient response through test stimulation, before doctors implant a permanent neurostimulator system in patients who demonstrate substantial symptom relief.

Sacral Neuromodulation Market- Market Dynamics

Increased awareness and improved reimbursement pathways

The sacral neuromodulation market experiences growth because two main factors drive its expansion, since better physician and patient education result in earlier diagnosis and increased acceptance of neuromodulation therapies to treat bladder and bowel disorders. The combinationof expanded clinical training programs with stronger clinical evidence and the inclusion of sacral neuromodulation in urology and gastroenterology treatment guidelines has increased physician confidence and referral rates. The combination of clear reimbursement frameworks with expanded insurance coverage in North America and selected European markets has decreased the financial expenses that patients need to pay for device implantation and subsequent treatment. The combination of enhanced awareness with better reimbursement systems has improved patient access to treatment, which results in faster adoption of sacral neuromodulation as standard therapy for refractory conditions and drives ongoing market growth.

Sacral Neuromodulation Market- Segmentation Analysis:

By Product Type

The Implantable Pulse Generators (IPGs) segment is expected to dominate the market over the forecast period. Sacral neuromodulation systems depend on IPGs which provide controlled electrical pulses that treat pelvic floor disorders through their direct connection to sacral nerves. The IPG devices serve as essential components for therapy operations which creates a direct link between their market demand and the adoption of sacral neuromodulation treatments that generate substantial revenue in the entire industry market. The ongoing development of technology through smaller device designs, extended battery operation, MRI compatibility, and programmable capabilities has made IPGs more beneficial for patients and doctors. The improvements lead to better patient comfort, which results in better clinical outcomes, and this effect increases both usage rates and product repurchases.

Sacral Neuromodulation Market- Geographical Insights

North America is expected to dominate the Sacral Neuromodulation market during the forecast period. The main reason for growth comes from the high occurrence of urinary and fecal incontinence, together with other pelvic floor disorders, which create a continuous need for effective neuromodulation treatments. The region enjoys benefits from its strong healthcare network, which provides multiple medical facilities that offer advanced treatment options and operate under established clinical methods for treating patients through procedures like sacral nerve stimulation. The United States and Canada now provide better reimbursement systems together with expanded insurance coverage, which reduces financial barriers that patients and healthcare facilities face, thereby increasing the availability and economic feasibility of sacral neuromodulation as a treatment option. The presence of major device manufacturers together with ongoing technological advancements in neuromodulation systems has led to the creation of better implantable devices that feature extended battery life and advanced programming functions, which help doctors choose these devices while patients become more willing to accept them, thus driving revenue growth in the North American market.

Sacral Neuromodulation Market- Competitive Landscape:

The sacral neuromodulation market functions through intense competition, which three major medtech companies Medtronic Axonics and Boston Scientific control while other established companies, including Abbott and various regional device manufacturers, compete. The market competition arises through three main factors which include technology differences that involve smaller MRI-safe rechargeable-free implantable pulse generators, better leads and programming software and the strength of distribution and clinical support, which helps doctors adopt new technologies. The current market environment results from legal and IP contests that have occurred between companies, while recent court decisions and active disputes have changed market competition and access. The market distribution keeps changing through ongoing product approvals, targeted M&A activities and strategic partnerships, while fast-growing Asian markets have become accessible for both agile competitors and local businesses to operate.

Recent Developments:

In June 2025, Neuspera(R) Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, announced that the U.S. Food and Drug Administration (FDA) has approved its integrated sacral neuromodulation (iSNM) system for the treatment of urinary urge incontinence (UUI).

In May 2025, Medtronic launched its next-generation InterStim X system featuring advanced wireless programming capabilities and extended battery life, significantly improving patient convenience and treatment outcomes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SACRAL NEUROMODULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • BioControl Medical
  • Uroplasty Inc.
  • Cogentix Medical Inc.
  • Cyberonics Inc.
  • Nuvectra Corporation
  • Nevro Corp.
  • Synapse Biomedical Inc.
  • ImThera Medical Inc.
  • Abbott Laboratories
  • Advanced Bionics AG
  • Stryker Corporation
  • Inspire Medical Systems Inc.
  • Laborie Medical Technologies
  • MicroTransponder Inc.
  • Brainsway Ltd.
  • EndoStim Inc.
  • Stimwave LLC

GLOBAL SACRAL NEUROMODULATION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • External/Non-Implantable Pulse Generators (EPGs)
  • Lead Electrodes
  • Implantable Pulse Generators (IPGs)
  • Accessories and System Components

GLOBAL SACRAL NEUROMODULATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Urinary Incontinence
  • Urinary Retention
  • Fecal Incontinence
  • Overactive Bladder
  • Chronic Pelvic Pain and Relative Pelvic Pain
  • Others

GLOBAL SACRAL NEUROMODULATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Large Medical Centers
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research and Academic Institutes

GLOBAL SACRAL NEUROMODULATION MARKET, BY PATIENT AGE GROUP- MARKET ANALYSIS, 2019 - 2032

  • Adult
  • Pediatric
  • Geriatric

GLOBAL SACRAL NEUROMODULATION MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Rechargeable Systems
  • Non-Rechargeable Systems
  • Wired/Lead Systems vs Wireless/Leadless Systems
  • Trial Systems vs Permanent Systems

GLOBAL SACRAL NEUROMODULATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Sacral Neuromodulation Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Sacral Neuromodulation Market Snippet by Product Type
    • 2.1.2. Sacral Neuromodulation Market Snippet by Application
    • 2.1.3. Sacral Neuromodulation Market Snippet by End User
    • 2.1.4. Sacral Neuromodulation Market Snippet by Patient Age Group
    • 2.1.5. Sacral Neuromodulation Market Snippet by Technology
    • 2.1.6. Sacral Neuromodulation Market Snippet by Country
    • 2.1.7. Sacral Neuromodulation Market Snippet by Region
  • 2.2. Competitive Insights

3. Sacral Neuromodulation Key Market Trends

  • 3.1. Sacral Neuromodulation Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Sacral Neuromodulation Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Sacral Neuromodulation Market Opportunities
  • 3.4. Sacral Neuromodulation Market Future Trends

4. Sacral Neuromodulation Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Sacral Neuromodulation Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Sacral Neuromodulation Market Landscape

  • 6.1. Sacral Neuromodulation Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Sacral Neuromodulation Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. External/Non-Implantable Pulse Generators (EPGs)
    • 7.1.3. Lead Electrodes
    • 7.1.4. Implantable Pulse Generators (IPGs)
    • 7.1.5. Accessories and System Components

8. Sacral Neuromodulation Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Urinary Incontinence
    • 8.1.3. Urinary Retention
    • 8.1.4. Fecal Incontinence
    • 8.1.5. Overactive Bladder
    • 8.1.6. Chronic Pelvic Pain and Relative Pelvic Pain
    • 8.1.7. Others

9. Sacral Neuromodulation Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals and Large Medical Centers
    • 9.1.3. Ambulatory Surgical Centers
    • 9.1.4. Specialty Clinics
    • 9.1.5. Research and Academic Institutes

10. Sacral Neuromodulation Market - By Patient Age Group

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Patient Age Group, 2024 & 2032 (%)
    • 10.1.2. Adult
    • 10.1.3. Pediatric
    • 10.1.4. Geriatric

11. Sacral Neuromodulation Market - By Technology

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 11.1.2. Rechargeable Systems
    • 11.1.3. Non-Rechargeable Systems
    • 11.1.4. Wired/Lead Systems vs Wireless/Leadless Systems
    • 11.1.5. Trial Systems vs Permanent Systems

12. Sacral Neuromodulation Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Sacral Neuromodulation Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Sacral Neuromodulation Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Sacral Neuromodulation Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Sacral Neuromodulation Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Sacral Neuromodulation Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Sacral Neuromodulation Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. BioControl Medical
    • 13.2.2. Uroplasty Inc.
    • 13.2.3. Cogentix Medical Inc.
    • 13.2.4. Cyberonics Inc.
    • 13.2.5. Nuvectra Corporation
    • 13.2.6. Nevro Corp.
    • 13.2.7. Synapse Biomedical Inc.
    • 13.2.8. ImThera Medical Inc.
    • 13.2.9. Abbott Laboratories
    • 13.2.10. Advanced Bionics AG
    • 13.2.11. Stryker Corporation
    • 13.2.12. Inspire Medical Systems Inc.
    • 13.2.13. Laborie Medical Technologies
    • 13.2.14. MicroTransponder Inc.
    • 13.2.15. Brainsway Ltd.
    • 13.2.16. EndoStim Inc.
    • 13.2.17. Stimwave LLC

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us